BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 7555484)

  • 1. Treatment of hypercholesterolemia in NIDDM with policosanol.
    Torres O; Agramonte AJ; Illnait J; Más Ferreiro R; Fernández L; Fernández JC
    Diabetes Care; 1995 Mar; 18(3):393-7. PubMed ID: 7555484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of policosanol in hypercholesterolemic postmenopausal women.
    Mirkin A; Mas R; Martinto M; Boccanera R; Robertis A; Poudes R; Fuster A; Lastreto E; Yañez M; Irico G; McCook B; Farré A
    Int J Clin Pharmacol Res; 2001; 21(1):31-41. PubMed ID: 11708573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of policosanol 20 versus 40 mg/day in the treatment of patients with type II hypercholesterolemia: a 6-month double-blind study.
    Castaño G; Mas R; Fernández L; Illnait J; Gámez R; Alvarez E
    Int J Clin Pharmacol Res; 2001; 21(1):43-57. PubMed ID: 11708574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial.
    Berthold HK; Unverdorben S; Degenhardt R; Bulitta M; Gouni-Berthold I
    JAMA; 2006 May; 295(19):2262-9. PubMed ID: 16705107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of addition of policosanol to omega-3 fatty acid therapy on the lipid profile of patients with type II hypercholesterolaemia.
    Castaño G; Fernández L; Mas R; Illnait J; Gámez R; Mendoza S; Mesa M; Fernández J
    Drugs R D; 2005; 6(4):207-19. PubMed ID: 16050054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
    Castaño G; Menéndez R; Más R; Amor A; Fernández JL; González RL; Lezcay M; Alvarez E
    Int J Clin Pharmacol Res; 2002; 22(3-4):89-99. PubMed ID: 12837046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the efficacy and tolerability of policosanol and lovastatin in patients with hypercholesterolemia and noninsulin dependent diabetes mellitus.
    Crespo N; Illnait J; Más R; Fernández L; Fernández J; Castaño G
    Int J Clin Pharmacol Res; 1999; 19(4):117-27. PubMed ID: 10939029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of policosanol on postmenopausal women with type II hypercholesterolemia.
    Castaño G; Más R; Fernández L; Fernández JC; Illnait J; López LE; Alvarez E
    Gynecol Endocrinol; 2000 Jun; 14(3):187-95. PubMed ID: 10923280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of policosanol in older patients with type II hypercholesterolemia and high coronary risk.
    Castaño G; Más R; Fernández JC; Illnait J; Fernández L; Alvarez E
    J Gerontol A Biol Sci Med Sci; 2001 Mar; 56(3):M186-92. PubMed ID: 11253161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of policosanol and pravastatin on lipid profile, platelet aggregation and endothelemia in older hypercholesterolemic patients.
    Castaño G; Más R; Arruzazabala ML; Noa M; Illnait J; Fernández JC; Molina V; Menéndez A
    Int J Clin Pharmacol Res; 1999; 19(4):105-16. PubMed ID: 10939028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant use of policosanol and beta-blockers in older patients.
    Castaño G; Mas R; Gámez R; Fernández J; Illnait J; Fernández L; Mendoza S; Mesa M; Gutiérrez JA; López E
    Int J Clin Pharmacol Res; 2004; 24(2-3):65-77. PubMed ID: 15689053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly patients with type II hypercholesterolaemia.
    Castaño G; Mas R; Fernández L; Illnait J; Mesa M; Alvarez E; Lezcay M
    Drugs Aging; 2003; 20(2):153-63. PubMed ID: 12534315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the effects of D-003 and policosanol (5 and 10 mg/day) in patients with type II hypercholesterolemia: a randomized, double-blinded study.
    Castaño G; Más R; Fernández L; Illnait J; Mendoza S; Gámez R; Fernández J; Mesa M
    Drugs Exp Clin Res; 2005; 31 Suppl():31-44. PubMed ID: 16444910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a policosanol supplement on serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects.
    Greyling A; De Witt C; Oosthuizen W; Jerling JC
    Br J Nutr; 2006 May; 95(5):968-75. PubMed ID: 16611388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of policosanol in patients with type II hypercholesterolemia and additional coronary risk factors.
    Más R; Castaño G; Illnait J; Fernández L; Fernández J; Alemán C; Pontigas V; Lescay M
    Clin Pharmacol Ther; 1999 Apr; 65(4):439-47. PubMed ID: 10223782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A randomized, double-blind, placebo-controlled study of the antilipemic efficacy and tolerability of food supplement policosanol in patients with moderate hypercholesterolemia].
    Tedeschi-Reiner E; Reiner Z; Romić Z; Ivanković D
    Lijec Vjesn; 2005; 127(11-12):273-9. PubMed ID: 16583932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hypercholesterolemia and combined hyperlipidemia with simvastatin and gemfibrozil in patients with NIDDM. A multicenter comparison study.
    Tikkanen MJ; Laakso M; Ilmonen M; Helve E; Kaarsalo E; Kilkki E; Saltevo J
    Diabetes Care; 1998 Apr; 21(4):477-81. PubMed ID: 9571327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative effects of policosanol and two HMG-CoA reductase inhibitors on type II hypercholesterolemia].
    Prat H; Román O; Pino E
    Rev Med Chil; 1999 Mar; 127(3):286-94. PubMed ID: 10436712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy, safety and tolerability of original policosanol versus other mixtures of higher aliphatic primary alcohols in patients with type II hypercholesterolemia.
    Castaño G; Fernández L; Mas R; Illnait J; Fernández J; Mesa M; Alvarez E; Lezcay M
    Int J Clin Pharmacol Res; 2002; 22(2):55-66. PubMed ID: 12503776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wheat germ policosanol failed to lower plasma cholesterol in subjects with normal to mildly elevated cholesterol concentrations.
    Lin Y; Rudrum M; van der Wielen RP; Trautwein EA; McNeill G; Sierksma A; Meijer GW
    Metabolism; 2004 Oct; 53(10):1309-14. PubMed ID: 15375787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.